Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (94)

« Back to Publications

En-risk to de-risk: An iterative human factors framework for scale development in emerging technologies.

Kantor J. et al, (2026), JAAD Int, 24, 342 - 345

Public attitudes towards intranasal and ultrasound mediated vaccine delivery: A cross-sectional study in the United Kingdom and United States.

Kantor J. et al, (2026), Vaccine, 69

Afterword

Vanderslott S., (2026), 167 - 171

Development and validation of the Oxford Benchmark Scale for Rating Vaccine Technologies (OBSRVT), a scale for assessing public attitudes to next-generation vaccine delivery technologies.

Kantor J. et al, (2025), Hum Vaccin Immunother, 21

Early lymph node T follicular helper cell signalling hub drives influenza vaccine response in an ancestrally diverse cohort.

Siu JHY. et al, (2025), EBioMedicine, 122

Discriminative Cut-Offs, Concurrent Criterion Validity, and Test-Retest Reliability of the Oxford Vaccine Hesitancy Scale.

Kantor J. et al, (2025), Vaccines (Basel), 13

WHO pandemic agreement.

Norton A. et al, (2025), BMJ, 390

A systematic review on patient and public attitudes toward health monitoring technologies across countries.

Chen T. et al, (2025), NPJ Digit Med, 8

Acceptability of the gonorrhoea human challenge model to accelerate vaccine development in UK men.

Firth C. et al, (2025), Vaccine, 54

Confronting the shortcomings of covid-19 vaccination will help us in future pandemics.

Vanderslott S., (2025), BMJ, 388

Artificial intelligence for modelling infectious disease epidemics.

Kraemer MUG. et al, (2025), Nature, 638, 623 - 635

LISTEN: lived experiences of Long COVID: a social media analysis of mental health and supplement use.

Martin S. et al, (2025), Front Big Data, 8

Effective altruism, technoscience and the making of philanthropic value.

Taillandier A. et al, (2025), Econ Soc, 54, 1 - 25

Roles and responsibilities of participants, researchers, and the media in the communication of vaccine trials: Experience from the United Kingdom's first COVID-19 vaccine trial.

Patrick-Smith M. et al, (2024), Vaccine, 42

Oxford Vaccine Hesitancy Scale (OVHS): a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess vaccine hesitancy.

Kantor J. et al, (2024), BMJ Open, 14

Load More

1
2
3
4
5
6
7